What is the price target for RNST stock?
13 analysts have analysed RNST and the average price target is 45.32 USD. This implies a price increase of 14.68% is expected in the next year compared to the current price of 39.515.
RENASANT CORP (RNST) Forecast, Price Target & Analyst Ratings
NYSE:RNST • US75970E1073
Current stock price
39.515 USD
-0.23 (-0.57%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RENASANT CORP (RNST).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 28, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.86
- Revenue Estimate
- 281.42M
Price Target Details & History
Consensus Price Target and Range
Mean target
$45.32
Upside
+ 14.68%
From current price of $39.52 to mean target of $45.32, Based on 13 analyst forecasts
Low
$43.43
Median
$45.90
High
$48.30
Price Target Revisions
1 Month
0.00%
3 Months
4.71%
Price Target Summary
13 Wall Street analysts provided a forecast for the next 12 months for RNST. The average price target is 45.32 USD. This implies a price increase of 14.68% is expected in the next year compared to the current price of 39.515.
The average price target has been revised upward by 4.71% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.08%
RNST was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RNST.
In the previous month the buy percentage consensus was at a similar level.
RNST was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-07 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-30 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-30 | Hovde Group | Upgrade | Market Perform -> Outperform |
| 2025-09-25 | TD Cowen | Initiate | Buy |
| 2025-05-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-04-24 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2025-04-02 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-01-30 | Keefe, Bruyette & Woods | Reiterate | Outperform -> Outperform |
| 2025-01-30 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-01-30 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-01-30 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-31 | Keefe, Bruyette & Woods | Reiterate | Outperform -> Outperform |
| 2024-11-13 | Hovde Group | Downgrade | Outperform -> Market Perform |
| 2024-09-20 | Truist Securities | Maintains | Hold -> Hold |
| 2024-08-05 | Hovde Group | Upgrade | Market Perform -> Outperform |
| 2024-08-05 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-08-02 | Keefe, Bruyette & Woods | Upgrade | Market Perform -> Outperform |
| 2024-07-31 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
| 2024-07-25 | Hovde Group | Downgrade | Outperform -> Market Perform |
| 2024-07-25 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2024-07-25 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-08 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-03 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2024-07-03 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-01 | Truist Securities | Maintains | Hold -> Hold |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 28, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.86
- Revenue Estimate
- 281.42M
- Revenue Q2Q
- 64.97%
- EPS Q2Q
- 29.88%
- Number of Analysts
- 9
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
1.36%
EPS (1 Month)
0.51%
EPS (3 Months)
3.69%
Next Earnings Summary
RNST is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is 0.86 USD and the consensus revenue estimate is 281.42M USD.
The next earnings revenue estimate has been revised upward by 1.36% in the past 3 months.
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 632.402M 0.29% | 715.856M 13.20% | 985.849M 37.72% | 1.157B 17.36% | 1.211B 4.67% | |
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A -1.39% | N/A -8.49% | N/A 63.41% | 474.58M 31.26% | 505.1M 6.43% | |
| Operating Margin | N/A | N/A | N/A | 41.02% | 41.71% | |
| EPS YoY % growth | 3.16 5.33% | 2.77 -12.34% | 3.03 9.39% | 3.64 20.18% | 3.90 7.17% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.86 29.88% | 0.90 31.14% | 0.93 21.15% | 0.95 4.53% | 0.92 7.59% | 0.97 6.86% | 1.01 8.47% | 1.02 7.45% |
| Revenue Q2Q % growth | 281.42M 64.97% | 287.48M 7.59% | 293M 8.70% | 295.41M 6.06% | 292.6M 3.97% | 300.43M 4.50% | 307.09M 4.81% | 310.14M 4.99% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 111.73M 91.61% | 117.63M 16.41% | 121.76M 11.86% | 122.91M 13.24% | 123.21M 10.27% | 129.49M 10.08% | 134.54M 10.50% | 135.79M 10.48% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
RENASANT CORP / RNST Forecast FAQ
Can you provide the upcoming earnings date for RENASANT CORP?
RENASANT CORP (RNST) will report earnings on 2026-04-28.
What are the consensus estimates for RENASANT CORP (RNST) next earnings?
The consensus EPS estimate for the next earnings of RENASANT CORP (RNST) is 0.86 USD and the consensus revenue estimate is 281.42M USD.
Can you provide the analyst count for RENASANT CORP stock?
The number of analysts covering RENASANT CORP (RNST) is 13.